Probiotic Supplements Explained: CFU Counts, Strain Identity and Why Viability Is the Real Specification

Most supplement ingredients are chemicals: a vitamin, a mineral salt, a plant extract. They can degrade over time, but they do not die. Probiotics are different. The active ingredient is a population of living bacteria or yeasts, and from the day a batch is made that population begins to decline. For a brand owner, this changes almost everything about how the product is specified, packed, stored, tested and labelled — and it is why a probiotic that looks identical to a competitor’s on the shelf can deliver a very different number of live organisms by the time a consumer opens it.

Quick answer: A probiotic is defined by the FAO and WHO as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. The dose is expressed in colony forming units (CFU) — an estimate of how many organisms are alive and able to multiply. Because counts fall during storage, the number that matters is the count at the end of shelf life, not at manufacture. Manufacturers manage this through strain selection, extra starting quantity (overage), very dry formulation, moisture-proof packaging and real-time stability testing. Brand owners should specify the exact strain, the guaranteed CFU at expiry, and the storage condition that guarantee depends on.

Key takeaways

• A probiotic’s identity is its strain, not just its species. Evidence for one strain does not automatically apply to another strain of the same species.
• CFU measures live, culturable organisms. A count stated “at time of manufacture” can be much higher than what remains at expiry.
• Moisture, heat and oxygen are the main causes of die-off. Packaging and water activity often matter more than the capsule itself.
• Overage — adding more organisms than the label claims — is normal practice, but it should be justified by stability data, not guessed.
• Gummies, drinks and tablets that involve heat, water or compression are harder formats for most probiotic strains than dry capsules or sachets.
• Probiotic claims are regulated like any other health claim. The strain, dose and evidence need to line up with what the label says.

Who this is for: founders and brand owners planning a probiotic or synbiotic supplement, and product teams adding a probiotic to an existing range, who need to understand what to specify to a manufacturer and which results to ask for.

What makes a probiotic different from other supplement ingredients?

A probiotic is only a probiotic while it is alive. Once the organisms die, the product may still contain bacterial material, but it no longer meets the definition.

The widely used definition comes from a 2001 expert consultation and 2002 working group convened by the Food and Agriculture Organization and the World Health Organization, published together in the FAO/WHO report Probiotics in food: Health and nutritional properties and guidelines for evaluation. In 2014 an expert panel of the International Scientific Association for Probiotics and Prebiotics (ISAPP) reviewed that definition and retained it with minor wording changes, in a consensus statement published in Nature Reviews Gastroenterology & Hepatology.

Three words in that definition carry the practical weight for manufacturing:

• Live — the organisms must be viable when consumed, which makes shelf life a biological problem, not just a chemical one.
• Adequate amounts — there has to be a dose, and it has to be measured.
• Health benefit — the benefit must be supported by evidence for that organism, which is why strain identity matters.

It also helps to separate probiotics from neighbouring terms that often appear on the same label. A prebiotic is a substrate, usually a fibre such as inulin or a galacto-oligosaccharide, that is selectively used by beneficial microorganisms. A synbiotic combines the two. A postbiotic, as ISAPP defined it in 2021, is a preparation of inanimate microorganisms or their components that confers a health benefit. Each term has different stability and testing implications, and they should not be used interchangeably on a pack.

Why does the strain matter more than the species?

Research on probiotics is strain-specific. Two strains of the same species can behave differently in the gut, survive processing differently and have different levels of clinical evidence behind them.

A fully identified probiotic is named at three levels: genus, species and strain. Lacticaseibacillus rhamnosus GG is an example — the genus and species describe the type of bacterium, and “GG” identifies the particular strain that has been studied. A label that says only “Lactobacillus blend” tells the consumer, and the regulator, very little.

Brand owners will also notice that many familiar names have changed. In 2020 the large Lactobacillus genus was reclassified into 25 genera based on genetic analysis, so Lactobacillus rhamnosus became Lacticaseibacillus rhamnosus and Lactobacillus plantarum became Lactiplantibacillus plantarum, while Lactobacillus acidophilus kept its name. The organisms did not change, but labels, specifications and registration documents need to use names consistently and should match the supplier’s certificate.

When selecting a strain, a manufacturer or brand owner will typically ask the culture supplier for:

• Genetic identification of the strain (commonly by DNA sequencing) and its deposit number in a recognised culture collection.
• Safety information, including antibiotic-resistance profiling.
• Published studies on that strain, at the dose the brand intends to use.
• Stability data in dry form and, ideally, in formats similar to the planned product.

What does a CFU count actually measure?

A colony forming unit is a single viable cell, or a small cluster of cells, that grows into a visible colony when spread on a nutrient plate. CFU is therefore an estimate of how many organisms in a sample are alive and able to multiply.

Photo: Pexels

In a laboratory, a sample of the finished product is dissolved and diluted in a series of tenfold steps, plated on a growth medium suited to the organism, incubated, and the colonies are counted. The count is multiplied back up by the dilution factor to give CFU per gram or per capsule. Multi-strain products may need several different media or conditions, because one plate rarely suits every organism in a blend.

Three limitations are worth knowing:

• Plate counts are variable. Results differ between laboratories and between repeat tests of the same sample, so specifications need a realistic tolerance and a defined method.
• Stressed cells may not grow on a plate. Organisms that are alive but damaged can be missed. Alternative methods such as flow cytometry, standardised for lactic acid bacteria in ISO 19344, count cells by staining rather than growth, and may give higher numbers.
• Blend totals hide the split. A label claiming “10 billion CFU” across eight strains says nothing about whether each strain is present at an effective level. Where the evidence is strain-specific, the count per strain matters.

The same principle discussed in reading a certificate of analysis applies here: a CFU result is only meaningful alongside its method, the sample it was taken from and the date it was tested.

“At manufacture” or “at expiry” — which CFU number should a label show?

The count that reflects what a consumer receives is the count at the end of the product’s shelf life. ISAPP and many industry quality guidelines recommend labelling on that basis.

A label that states CFU “at time of manufacture” is not necessarily wrong, but it describes a number that will not exist by the time most units are used. The difference can be large: depending on strain, format and storage, a product may lose a substantial share of its live count over a two-year shelf life.

This is where overage comes in. Manufacturers deliberately add more organisms than the label claim, so that after the expected die-off the product still meets its declared count at expiry. How much overage is needed depends on the strain, the formula and the packaging, and it should be set from stability data rather than a rule of thumb. Excessive overage adds cost; too little leads to out-of-specification results late in shelf life.

What causes probiotics to die during manufacturing and storage?

Most probiotic strains used in supplements are supplied as freeze-dried powders. In that dry, dormant state they can survive for long periods, but they are sensitive to four stresses:

Stress	Where it occurs	Typical control
Moisture	Hygroscopic excipients, humid production rooms, permeable packaging	Low-water-activity excipients, humidity-controlled filling, desiccants, foil blisters or sealed sachets
Heat	Warm warehouses, shipping, heated processes such as gummy depositing	Cool storage, temperature-aware logistics, heat-tolerant or spore-forming strains for heated formats
Oxygen	Headspace in bottles, repeated opening	Nitrogen flushing, oxygen barrier packaging, unit-dose formats
Mechanical and chemical stress	Tablet compression, acidic or reactive co-ingredients	Capsules or powders instead of tablets, compatibility testing of every ingredient in the blend

Moisture is usually the dominant factor in a tropical climate. Manufacturers control it by keeping the water activity of the finished powder very low, which means choosing dry, non-hygroscopic excipients and filling in humidity-controlled rooms. A formula that performs well in a temperate warehouse can lose viability much faster in a hot, humid supply chain, which is why stability conditions should reflect where the product will actually be stored and sold. The broader principles are covered in stability testing and shelf life.

Co-ingredients also matter. Some botanical extracts, minerals and vitamins can reduce probiotic survival, and adding a prebiotic fibre can raise the moisture content of a blend. Every ingredient added to a probiotic formula should be checked for compatibility, not just for its own benefit.

Which dosage forms work best for probiotics?

The format decides how much stress the organisms face before they reach the consumer. As a general comparison:

• Capsules — the most common format. No heat or compression, and capsules can be packed in foil blisters or desiccated bottles. Delayed-release or acid-resistant capsules are sometimes used to improve survival through the stomach.
• Powder sachets and stick packs — good moisture protection per dose and suitable for higher doses or children’s products, but each sachet must be well sealed.
• Tablets and chewables — compression and heat from friction reduce survival for many strains; formulation work is usually needed.
• Gummies — the depositing process involves heat and water, which most non-spore-forming strains do not survive. Spore-forming species, such as strains historically sold as Bacillus coagulans, are often used instead because their spores are far more heat-tolerant.
• Liquids and drinks — usually require refrigeration and have short shelf lives, and are often regulated as foods rather than supplements.

The trade-offs between these formats are discussed in more detail in choosing a supplement dosage form. For probiotics, format selection should come after strain selection, because the strain’s tolerance to heat and moisture limits which formats are realistic.

What tests should a brand owner expect for a probiotic product?

A probiotic batch is tested in two directions at once: confirming that the intended organisms are present at the right level, and confirming that unintended organisms are not.

• Viable count (CFU) against the label claim, at release and throughout stability.
• Identity of the strains, usually by the culture supplier’s certificate backed by periodic verification.
• Microbial purity — the absence of pathogens such as Salmonella and E. coli. This needs methods that can distinguish contaminants from a product that is deliberately full of bacteria. The general principles are covered in contaminant and microbial limit testing.
• Water activity or moisture of the finished blend, as a leading indicator of stability.
• Real-time stability at the intended storage condition, with CFU tested at intervals to the end of the proposed shelf life. Accelerated data can guide early decisions but should be confirmed.

Testing is part of a health supplement manufacturing programme rather than a one-off event. Viability results in particular need to be tracked across batches, because a gradual decline in starting counts from a culture supplier may only show up as a trend.

How are probiotic products regulated in Malaysia?

In Malaysia, probiotic products sold in capsule, tablet or powder form as health supplements fall under the product registration framework of the National Pharmaceutical Regulatory Agency (NPRA). The documentation expected for registration — including ingredient identity, finished-product specifications and stability data — is described in NPRA’s guidelines for health supplements. Brand owners should confirm the current requirements for strain naming, viable-count declarations and permitted claims directly with NPRA before finalising a label, because these details are updated over time.

Probiotic foods and drinks, such as cultured milk beverages, are generally handled under food law administered by the Ministry of Health’s Food Safety and Quality Division rather than as supplements. The product classification decides the regulatory path, as explained in how product classification works.

Claims deserve particular care. “Supports digestive health” for a specific strain at a studied dose is a very different statement from a disease-related claim, and general wording should not borrow evidence from a different strain. The wider rules are set out in what health and beauty brands can legally claim.

What should a brand owner specify to a manufacturer?

A clear probiotic specification prevents most of the disputes that arise later. At minimum, it should state:

• Each strain by full name and strain designation, and the approved culture supplier.
• The guaranteed CFU per daily dose at end of shelf life, per strain where relevant, and the test method.
• The storage condition on which that guarantee depends (for example, “store below 25°C” or refrigerated).
• The dosage form and the packaging, including desiccant or blister specification.
• The proposed shelf life and the stability study that will support it.
• Microbial purity and water activity limits for release.
• Who owns the stability data and what happens if a batch falls below claim before expiry.

Frequently asked questions

Is a higher CFU number always better?

No. The appropriate dose is the one used in studies on that specific strain. A very high total count across many strains does not guarantee that any single strain is present at an effective level.

Do all probiotics need to be refrigerated?

Not all. Many freeze-dried strains in well-protected capsules or sachets are formulated to be stable at room temperature, provided stability data supports it. Refrigeration still slows die-off, so the label storage instruction should match the condition used in stability testing.

Why do some probiotic capsules come in foil blisters instead of bottles?

Blisters protect each capsule from moisture and oxygen until it is used. In a bottle, every opening lets in humid air, which can shorten viability for sensitive strains.

Can a probiotic be added to a gummy or a coffee sachet?

It can, but usually only with strains that tolerate heat and moisture, such as spore-forming species. Standard lactic acid bacteria rarely survive these processes at meaningful levels.

My supplier changed the culture source. Does anything need to be retested?

Yes. A different strain, supplier or even production site for the culture can change viability and identity results, so it should go through the change control process with fresh stability data.

Is a postbiotic the same as a dead probiotic?

Not exactly. A postbiotic is a deliberately prepared, characterised preparation of inanimate microorganisms or their components with evidence of a health benefit. A probiotic that has simply died on the shelf is a failed probiotic, not a postbiotic.

Limitations

This article explains general principles as of September 2026 and is not regulatory, medical or legal advice. Probiotic evidence is strain- and dose-specific, and nothing here should be read as a claim that any probiotic treats or prevents disease. Malaysian registration requirements for products containing live microorganisms should be confirmed directly with NPRA. Viability losses vary widely by strain, formula, packaging and climate, so no typical figures are given.

Sources

• Food and Agriculture Organization of the United Nations and World Health Organization, Probiotics in food: Health and nutritional properties and guidelines for evaluation (FAO Food and Nutrition Paper 85).
• Hill C. et al., “The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic”, Nature Reviews Gastroenterology & Hepatology 11, 506–514 (2014).
• International Scientific Association for Probiotics and Prebiotics, Probiotics resources.
• National Pharmaceutical Regulatory Agency (NPRA), Guidelines for Health Supplements.

---

Creaton Poh is the pen name of Poh Tze Kheng, founder of ORIZI Group — one of Malaysia's most comprehensive one-stop OEM, ODM, private label and contract manufacturing groups, spanning skincare, cosmetics, personal care, perfume and fragrance, supplements, functional food and nutrition, pet care, home care and medical devices. Across six specialised companies and three manufacturing divisions, the Group brings together 20+ years of industry experience, 5,000+ formulations, and internationally recognised quality, manufacturing and regulatory standards. These articles are written to educate, not to promote.

Written by Creaton Poh
Industry Researcher • Author • Vlogger • Manufacturing Strategist
Turning ideas into products. Turning experience into knowledge.

Connect with Poh Tze Kheng on LinkedIn.